-
Symbol
-
BCLI on Nasdaq
-
Investment type
-
Equity - Shares of Stock
-
Class
-
Common Stock, $0.00005 par value
-
Latest Disclosed Ownership
-
300K shares
-
Security Ownership
-
4.99%
Armistice Capital, LLC ownership in BRAINSTORM CELL THERAPEUTICS INC. Common Stock, $0.00005 par value (BCLI)
2025-02-14 - Armistice Capital, LLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 300K shares of BRAINSTORM CELL THERAPEUTICS INC. Common Stock, $0.00005 par value (BCLI).
This represents 4.99% percent ownership of the company.